SCHEMBL6736952

SCHEMBL6736952

c1ccc(Oc2ccc(-c3cncc(-c4ccc(Oc5ccccc5)cc4)n3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
LTA4H P09960 5/20 0.51
MCL1 Q07820 2/20 0.50
CHEK1 O14757 1/20 0.50
CYP11B2 P19099 3/20 0.49
CYP11B1 P15538 2/20 0.49
TSHR P16473 1/20 0.48
XDH P47989 1/20 0.47
MEN1 O00255 1/20 0.46
GLA P06280 1/20 0.46
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GSTP1 P09211 1/20 0.46
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
SCN4A P35499 2/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125825 0.88 NPC1 (0.49) NPC1RAB9ALTA4HMCL1CHEK1
SCHEMBL28342834 0.82 RAB9A (0.67) NPC1RAB9ALTA4HMCL1CYP11B2
SCHEMBL3129027 0.81 MCL1 (0.53) NPC1RAB9AMCL1GLAHPGD
SCHEMBL13996075 0.80 MEN1 (0.62) NPC1RAB9ACHEK1CYP11B2CYP11B1
SCHEMBL27875172 0.79 CYP2C9 (0.57) NPC1RAB9ALTA4HCYP11B2CYP11B1
SCHEMBL14801814 0.78 MCL1 (0.71) NPC1RAB9AMCL1XDHMEN1
SCHEMBL4995514 0.78 HPGD (0.46) NPC1RAB9ALTA4HCHEK1HPGD
SCHEMBL21882397 0.76 MCL1 (0.69) NPC1RAB9AMCL1XDHMEN1
SCHEMBL21882451 0.76 MCL1 (0.69) NPC1RAB9AMCL1XDHMEN1
SCHEMBL13203160 0.76 MCL1 (0.69) NPC1RAB9AMCL1XDHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082627-A1 Certain aromatic monocycles as kinase modulators CGI PHARMACEUTICALS, INC. 2004-04-29 US disclosed
WO-2004000820-A2 CERTAIN AROMATIC MONOCYCLES AS KINASE MODULATORS CELLULAR GENOMICS, INC. (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082627-A1 Certain aromatic monocycles as kinase modulators MAP3K20, MAP3K1, MAP3K19 NPC1 3477/4885RAB9A 2270/4885LTA4H 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.